Core Insights - Kelyniam Global, Inc. has secured an exclusive U.S. license from Evonik Industries AG to market VESTAKEEP® Fusion, a bi-calcium phosphate-infused PEEK material for cranial, craniofacial, and maxillofacial implants, with a two-year exclusivity period and an option for renewal [1][2][3] Company Developments - The incorporation of VESTAKEEP® Fusion enhances Kelyniam's regenerative product lineup by leveraging its osteoconductive properties, which promote human bone growth and integration [2][4] - This strategic move is expected to add significant value for shareholders by expanding Kelyniam's regenerative medicine portfolio, positioning the company to meet the increasing demand for innovative cranial reconstruction solutions [3][4] Product and Market Positioning - Kelyniam's partnership with Modern Plastics ensures reliable access to PEEK materials, supporting the company's growth in advanced neurosurgical solutions [2][3] - The introduction of VESTAKEEP® Fusion reflects Kelyniam's commitment to delivering regenerative technologies that improve patient outcomes and advance the standard of care in cranial and craniofacial solutions [4]